IDEA trial: Skipping radiotherapy safe for younger postmenopausal patients with early-stage breast cancer : vimarsana.com

Almost all postmenopausal patients aged 50-69 years with stage I hormone receptor (HR)-positive breast cancer and low scores on a common genetic test who opted out of adjuvant radiotherapy were disease free five years after surgery, according to results from the IDEA clinical trial presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.

Related Keywords

San Antonio , Texas , United States , American , Lawrencew Davis , Reshma Jagsi , Emory University School Of Medicine , Doris Duke Foundation , Winship Cancer Institute Of Emory University , University Of Michigan Rogel Cancer Center , American Cancer Society , Susang Komen Breast Cancer Foundation , Genentech , National Institutes Of Health , American Association For Cancer Research , Greenwall Foundation , San Antonio Breast Cancer Symposium , Emory University School , Winship Cancer Institute , Breast Cancer Foundation , Michigan Rogel Cancer , Equity Quotient , National Institutes , Hawks Quindel , Breast Cancer , Ancer , Adiotherapy , Linical Trial , Ndocrine , Enetic , Ormone , Edicine , Ncology , Eceptor , Urgery ,